Related Experiment Videos
Alternate site blood glucose testing: do patients prefer it?
1Department of Diabetes, Hope Hospital, Salford, UK.
Summary
Patients found the Soft-Sense alternate site blood glucose testing device easier to use and less painful than their current methods. This device accurately measures blood glucose levels, offering a preferred alternative for diabetes management.
Area of Science:
- Medical Devices
- Diabetes Management
- Clinical Performance Evaluation
Background:
- Alternate site testing (AST) offers potential benefits for patients managing diabetes.
- Assessing patient experience and analytical accuracy is crucial for adopting new glucose monitoring devices.
Purpose of the Study:
- To compare patient-reported ease of use and pain with the MediSense Soft-Sense device versus current methods.
- To evaluate the analytical performance of the Soft-Sense device against a laboratory reference method.
Main Methods:
- Patients tested the Soft-Sense device on their forearm and finger.
- Blood samples were analyzed using the Soft-Sense device and a YSI Glucose Analyzer.
- Patient questionnaires assessed device usability and pain compared to existing methods.
Main Results:
- A significant majority of patients preferred Soft-Sense for ease of use (93%) and reduced pain (96%).
- Glucose results from Soft-Sense showed close correlation with the laboratory method (bias ranging from 5.7% to 11.0%).
- Error grid analysis confirmed all Soft-Sense glucose readings were clinically acceptable.
Conclusions:
- The Soft-Sense device is preferred by patients over their current glucose testing methods.
- The MediSense Soft-Sense device provides accurate whole blood glucose measurements for diabetes self-management.